Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 39.7 to 29.
Financials
Financial year 2025
EDWARDS LIFESCIENCES BELGIUM from Vilvoorde, company number BE0469903830, closed financial year 2025 with a result of € 573,081 after tax. For that financial year EDWARDS LIFESCIENCES BELGIUM recorded revenue of € 14 million and equity of € 5.3 million. Compared with financial year 2024, the result moved from € 917,922 to € 573,081. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ 5.3 million
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 573,081
▼ 38% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 4.6 million.
People and assets in 2025
29
▼ 7.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 6.5 million
▼ 3% vs 2024
€ 222,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 8,630
▼ 44% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2.2 million
▲ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 67 days on average.
€ 2 million
▲ 61% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 18,079,908 | € 19,393,713 | € 18,166,201 | € 13,957,832 | ▼ 23% |
| Profit after taxes | € 541,529 | € 713,305 | € 917,922 | € 573,081 | ▼ 38% |
| Equity | € 3,070,153 | € 3,783,458 | € 4,701,380 | € 5,274,461 | ▲ 12% |
| Total debts | € 6,211,122 | € 5,369,297 | € 3,170,657 | € 4,559,199 | ▲ 44% |
| Retained profit | € 2,426,153 | € 3,139,458 | € 4,057,380 | € 4,630,461 | ▲ 14% |
| Bank debt | € 19,596 | € 19,596 | € 0 | € 0 | |
| Balance sheet total | € 9,281,275 | € 9,152,755 | € 7,872,036 | € 9,833,660 | ▲ 25% |
| Employees (FTE) | 38.9 | 39.7 | 36.7 | 29 | ▼ 7.7 |
Key figures of EDWARDS LIFESCIENCES BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to EDWARDS LIFESCIENCES BELGIUM?
What happened at EDWARDS LIFESCIENCES BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 573,081 (▼ 38% vs 2024). Source: NBB ↗
- Andrew Dahl became a director. NBB
- Linda Park became a director. NBB
- Patrice Cappelle became a director. NBB
- New establishment in Vilvoorde. KBO
- Start of the company according to the CBE. KBO
In short
From € 541,529 profit in 2022 to € 573,081 profit in 2025.
Paid € 1.1 million in corporate taxes since 2022.
Best year ever: 2024, with € 917,922 profit.
Pays suppliers within 67 days on average.
A new publication or filing at EDWARDS LIFESCIENCES BELGIUM? We notify you, reason included.
Follow EDWARDS LIFESCIENCES BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind EDWARDS LIFESCIENCES BELGIUM are Patrice Cappelle, Andrew Dahl and Linda Park. The shares are held by Edwards Lifesciences (US) Inc (100%).
Directors
According to the 2025 annual accounts
Patrice Cappelle
Director
since 2015
Andrew Dahl
Director
since 2024
Linda Park
Director
since 2018
Shareholders
Edwards Lifesciences (US) Inc
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Medialaan 28B
1800 Vilvoorde
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
AMAZON-02 - Amazon.com, Inc., US
DNS
AWS Route 53
Domain
Domain
edwards.com
Registered
1994-04-25
Registrar
CSC Corporate Domains, Inc.
Expires
2026-04-26
Website info
Features
Security
Network
Details
- Company number
- 0469.903.830
- VAT number
- BE 0469.903.830
- Registered office
- Medialaan 28B, 1800 Vilvoorde
- Names & denominations
- EDWARDS LIFESCIENCES BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 January 2000
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- edwards.com
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Vervaardiging van elektrische apparaten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde
Vervaardiging van niet-elektrische apparaten en instrumenten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde